维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

16篇 您的检索式：作者名="BUI BN"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Discontinuation of imatinib in patients with advanced gastrointestinal stromal tumours after 3 years of treatment: an open-label multicentre randomised phase 3 trial 显示文摘	Le Cesne A Ray-Coquard I Bui BN	2010	Lancet Oncol2010，11，10：	1
	2	Imatinib for progressive and recurrent aggressive fibromatosis (desmoid tumors): an FNCLCC/French Sarcoma Group phase 1I trial with a long- term follow-up显示文摘	Penel N Le Cesne A Bui BN	2011	Ann Oncol2011，22，2：	1
	3	Prognostic factors inlocalized E-wing's tumours and peripheral neuroectoder-mal tumours:the third study of the French society ofP aediatric oncology(EW88 study)显示文摘	Oberlin O Deley MC Bui BN	2001	Br J Cancer2001，85，11：	1
	4	Imatinib for progressive and recurrent aggressive fibromatosis (desmoid tumors): an FNCLCC/French Sarcoma Group phase Ⅱ trial with a long- term follow-up显示文摘	Penel N Le Cesne A Bui BN	2011	Ann Oncol2011，22，2：	1
	5	Discontinuation of ima- tinib in patients with advanced gastrointestinal stromal tumours af- ter 3 years of treatment: an open-label muhicentre randomised phase 3 trial显示文摘	Le CA Ray-Coquard I Bui BN	2010	Lancet Oncol2010，11，10：	1
	6	Discontinuation of imatinib in patients with advanced gastrointestinal stromal tumours after 3 years of treatment:an open-label multicentre randomised phase 3 trial显示文摘	Le Cesne A Ray-Coquard I Bui BN	2010	Lancet Oncol2010，11，：	1
	7	Discontinuation of imatinib in patients with advanced gastrointestinal stromal tumours after 3 years of treatment: an open-label multicentre randomised phase 3 trial显示文摘	LE CESNE A RAY-COQUARD 1 BUI BN	2010	Lancet Oncol2010，11，10：	1
	8	French society of paediatric oncology: prognostic factors in localized Ewing's tumours and peripheral neuroectodermal tumours: the third study of the french society of paediatric oncology (EW88 study) 显示文摘	Oberlin O Deley MC Bui BN	2001	Br J Cancer2001，85，11：	1
	9	Phase II clinical trial of neoadjuvant trabectedin in patients with advanced localized myxoid liposarcoma显示文摘	Gronchi A Bui BN Bonvalot S		0，，：	1
	10	A FNCLCC French Sarcoma Group--GETO multicenter randomized phase Ⅱ study of gemcitabine (G) versus gemcitabine and docetaxel (G+D) in patients with metastatic or relapsed leiomyosarcoma (LMS)显示文摘	Duffaud F Bui BN Penel N	2008	J Clin Oncol2008，26，10：	1
	11	Prognostic factors in localized Ewing's tumours and peripheral neuroectoder- mal tumours: the third study of the French society of Paediatric oncology (EW88 study)显示文摘	Oberlin O Deley MC Bui BN	2001	Br J Cancer2001，85，11：	1
	12	Phase Ⅱ trial of weekly paclitax- el for unresectable angiosarcoma: the ANGIOTAX Study 显示文摘	Penel N Bui BN Bay J	2008	J Clin Oncol2008，26，32：	1
	13	Imatinib for progres- sive and recurrent aggressive fibromatosis (desmoid tu- mors): An FNCLCC/French Sarcoma Group phase Ⅱ trial with a long-term follow-up显示文摘	Penel N Le Cesne A Bui BN	2011	Ann Oncol2011，22，2：	1
	14	A FNCLCC French Sarcoma Group--GETO multicenter randomized phase 11 study of gemcitabine (G) versus gemcitabine and doceta-xel (G +D) in patients with metastatic or relapsed leiomyosarcoma (LMS)显示文摘	Duffaud F Bui BN Penel N	2008	J Clin Oncol 26: 2008(May 20 suppl2008，，：	1
	15	A FNCLCC French Sarcoma Group - - GETO muhicenter randomized phase II study of gemcitabine (G) versus gemcitabine and docetaxel ( G + D ) in patients with metastatic or relapsed leiomyosarcoma (LMS) 显示文摘	Duffaud F Bui BN Penel N	2008	JClin Oncol2008，，10：	1
	16	Discontinuation of imatinib in patients with advanced gastrointestinal stromal tumours after 3 years of treatment: an open-label multicentrc randomised phase 3 trial 显示文摘	Le Cesne A Ray-Coquard I Bui BN	2010	Lancet Oncol2010，11，10：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费